Peyton R. Howell - Aug 3, 2021 Form 4 Insider Report for TANDEM DIABETES CARE INC (TNDM)

Role
Director
Signature
s/ David B. Berger, Attorney-in-Fact for Peyton R. Howell
Stock symbol
TNDM
Transactions as of
Aug 3, 2021
Transactions value $
$0
Form type
4
Date filed
8/5/2021, 05:57 PM
Previous filing
May 20, 2021
Next filing
May 10, 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction TNDM Common Stock Options Exercise $0 +948 $0.00 948 Aug 3, 2021 Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction TNDM Restricted Stock Unit Options Exercise $0 +948 +99.79% $0.00 1.9K Aug 3, 2021 Common Stock 948 Direct F1, F2, F3, F4
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Granted pursuant to the Tandem Diabetes Care, Inc. 2013 Stock Incentive Plan (the 2013 Plan).
F2 Each restricted stock unit (RSU) represents a contingent right to receive one share of common stock of the Company.
F3 This RSU award was granted on August 3, 2020. 33% of the RSU vested on August 3, 2021 and the remaining shares will vest over a period of two years in equal annual installments on the anniversary of the grant, subject to the terms of the 2013 Plan.
F4 RSU vest as to thirty-three percent (33%) of the total number of shares subject to the RSU on 8/3/2021, and the remaining shares shall vest in two (2) equal annual installments thereafter.